Price $36.60 |
Market Cap
2.71B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.95
|
P/S
14.87
|
Dividend %
-
|
|
P/CF
13.0
|
P/FCF
-
|
Op. Cash Flow
-352.4K
|
FCF
-5.7
|
|
Op. Margin
-187.40%
|
Net Margin
-182.50%
|
ROE
-59.70%
|
ROI
-
|
|
ROA
-40.30%
|
EPS Growth
20.50%
|
Current Ratio
6.6
|
Debt/Equity
0.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Tivity Health Inc (TVTY) | $14.30 | - | - | 783.8M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.81 | - | - | 70.1M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $8.85 | - | - | 10.43B | Strong Buy |
| American Bio Medica Corporatio (ABMC) | $0.13 | - | - | 10M | Strong Buy |
| IRIDEX Corporation (IRIX) | $1.82 | - | - | 28.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
